FFCP PHASE2:Hg19::chr1:45205478..45205492,+
From FANTOM5_SSTAR
Jump to: navigation, search
Short description: | p4@KIF2C |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_4_at_KIF2C_5end |
Coexpression cluster: | C109_Reticulocytes_non_acute_Hodgkin_Burkitt_retinoblastoma_lymphoma |
Association with transcript: | 0bp_to_ENST00000372224, ENST00000452259, NM_006845, uc001cmg.3, uc010olb.1_5end |
EntrezGene: | KIF2C |
HGNC: | 6393 |
UniProt: | Q99661Q5JR91 |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
Sample | p4@KIF2C |
---|
0
2
4
6
8
10
12
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
cancer | 2.68e-29 | 235 |
disease of cellular proliferation | 7.93e-28 | 239 |
hematologic cancer | 5.93e-20 | 51 |
immune system cancer | 5.93e-20 | 51 |
leukemia | 7.57e-18 | 39 |
organ system cancer | 1.56e-17 | 137 |
myeloid leukemia | 1.38e-12 | 31 |
cell type cancer | 5.55e-12 | 143 |
carcinoma | 4.26e-09 | 106 |
chronic leukemia | 3.96e-08 | 8 |
Showing 1 to 10 of 10 entries